Clough Capital is a Boston-based boutique asset manager and SEC-registered investment adviser founded in 1999. The firm manages actively managed portfolios across ETFs, closed-end funds, separately managed accounts and limited partnerships, and is relevant to founders primarily as a later-stage U.S. co-investor with life sciences, biotechnology, oncology and pharmaceutical investment signals.